Noncutaneous melanoma have distinct features from each other and cutaneous melanoma

Oncology

Volumn 81, Issue 5-6, 2012, Pages 353-358

  Tas, Faruk ^a   Keskin, Serkan ^a   Karadeniz, Ahmet ^a   Daǧoǧlu, Nergiz ^a   Sen, Fatma ^a   Kilic, Leyla ^a   Yildiz, Ibrahim ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Mucosal melanoma; Noncutaneous melanoma; Ocular melanoma; Unknown primary melanoma

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN; DACARBAZINE; FOTEMUSTINE; IODINE 125; TEMOZOLOMIDE;

ADJUVANT THERAPY; ADVANCED CANCER; AGE; ANUS CANCER; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER OF UNKNOWN PRIMARY SITE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COLON CANCER; CONJUNCTIVA TUMOR; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISTANT METASTASIS; ENUCLEATION; ESOPHAGUS CANCER; EYE MELANOMA; FEMALE; FEMALE GENITAL TRACT CANCER; GENDER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; MUCOSAL MELANOMA; NONCUTANEOUS MELANOMA; NOSE CANCER; OVERALL SURVIVAL; PARANASAL SINUS CANCER; PRIORITY JOURNAL; RECTUM CANCER; REGIONAL METASTASIS; URINARY TRACT CANCER; UVEA MELANOMA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84855799136     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000334863     Document Type: Article

References (29)

1. Ross MI, Henderson MA: Mucosal melanoma; in Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF (eds): Cutaneous Melanoma, ed 5. St. Louis, Quality Medical, 2009, pp 337-349.
2. Scotto J, Fraumeni JF II, Lee JA: Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 1976; 56: 489-491.
3. Iversen K, Robins RE: Mucosal malignant melanomas. Am J Surg 1980; 139: 660-664. (Pubitemid 10102041)
4. Chang AE, Karnell LH, Menck HR: The national cancer data base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade - The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998; 83: 1664-1678. (Pubitemid 28465486)
5. Hayat MJ, Howlader N, Reichman ME, Edwards BK: Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology and End Results (SEER) Program. Oncologist 2007; 12: 20-37. (Pubitemid 46143500)
6. Inskip PD, Devesa SS, Fraumeni JF Jr: Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control 2003; 14: 251-257. (Pubitemid 36656335)
7. Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E: Incidence of uveal melanoma in Europe. Ophthalmology 2007; 114: 2309-2315.
8. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Bröcker EB, LeBoit PE, Pinkel D, Bastian BC: Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 2135-2147. (Pubitemid 41653105)
9. Curtin JA, Busam K, Pinkel D, Bastian BC: Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24: 4340-4346. (Pubitemid 46630793)
10. Tas F, Kurul S, Camlica H, Topuz E: Malignant melanoma in Turkey: a single institution's experience on 475 cases. Jpn J Clin Oncol 2006; 36: 794-799. (Pubitemid 47090735)
11. McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW: Incidence of noncutaneous melanomas in the U.S. Cancer 2005; 103: 1000-1007. (Pubitemid 40270077)
12. Kim HS, Kim EK, Jun HJ, Oh SY, Park KW, Lim do H, Lee SI, Kim JH, Kim KM, Lee DH: Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study. BMC Cancer 2010; 10: 167.
13. Pandey M, Mathew A, Abraham EK, Ahamed IM, Nair KM: Primary malignant melanoma of the mucous membranes. Eur J Surg Oncol 1998; 24: 303-307. (Pubitemid 28403420)
14. DeMatos P, Tyler DS, Seigler HF: Malignant melanoma of the mucous membranes: a review of 119 cases. Ann Surg Oncol 1998; 5: 733-742. (Pubitemid 28565726)
15. Thompson LD, Wieneke JA, Miettinen M: Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003; 27: 594-611. (Pubitemid 36514471)
16. Pandey M, Mathew A, Iype EM, Sebastian P, Abraham EK, KM N: Primary malignant mucosal melanoma of the head and neck region: pooled analysis of 60 published cases from India and review of literature. Eur J Cancer Prev 2002; 11: 3-10. (Pubitemid 34233071)
17. Patrick RJ, Fenske NA, Messina JL: Primary mucosal melanoma. J Am Acad Dermatol 2007; 56: 828-834. (Pubitemid 46560994)
18. Moreno MA, Hanna EY: Management of mucosal melanomas of the head and neck: did we make any progress? Curr Opin Otolaryngol Head Neck Surg 2010; 18: 101-106.
19. Thoelke A, Willrodt S, Hauschild A, Schadendorf D: Primary extracutaneous malignant melanoma: a comprehensive review with emphasis on treatment. Onkologie 2004; 27: 492-499. (Pubitemid 39664165)
20. Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH, Boyle JO, Huvos AG, Busam K, Shah JP: Primary mucosal malignant melanoma of the head and neck. Head Neck 2002; 24: 247-257. (Pubitemid 34193249)
21. Mucke T, Holzle F, Kesting MR, Loeffelbein DJ, Robitzky LK, Hohlweg-Majert B, Tannapfel A, Wolff KD: Tumor size and depth in primary malignant melanoma in the oral cavity influences survival. J Oral Maxillofac Surg 2009; 67: 1409-1415.
22. Richtig E, Langmann G, Mullner K, Smolle J: Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi. Ophthalmologica 2004; 218: 111-114. (Pubitemid 38338474)
23. Damato B, Dopierala JA, Coupland SE: Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 2010; 16: 6083-6092.
24. Krema H, Somani S, Sahgal A, Xu W, Heydarian M, Payne D, McGowan H, Michaels H, Simpson ER, Laperriere N: Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up. Br J Ophthalmol 2009; 93: 1172-1176.
25. Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E: Survival in patients with uveal melanoma in Europe. Arch Ophthalmol 2008; 126: 1413-1418.
26. Prens SP, van der Ploeg AP, van Akkooi AC, van Montfort CA, van Geel AN, de Wilt JH, Eggermont AM, Verhoef C: Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site. Ann Surg Oncol 2011; 18: 3586-3592.
27. Pfeil AF, Leiter U, Buettner PG, Eigentler TK, Weide B, Meier F, Garbe C: Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009. Melanoma Res 2011; 21: 228-234.
28. Chao C, Martin RC II, Ross MI, Reintgen DS, Edwards MJ, Noyes RD, Hagendoorn LJ, Stromberg AJ, McMasters KM: Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004; 11: 259-264. (Pubitemid 40486765)
29. Lengyel E, Gilde K, Remenar E, Esik O: Malignant mucosal melanoma of the head and neck. Pathol Oncol Res 2003; 9: 7-12. (Pubitemid 36604533)